echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Cell: Zhou Dawang/Chen Lanfen's research group jointly published a paper revealing the important mechanism of glycogen accumulation and phase separation driving the initiation of liver cancer

    Cell: Zhou Dawang/Chen Lanfen's research group jointly published a paper revealing the important mechanism of glycogen accumulation and phase separation driving the initiation of liver cancer

    • Last Update: 2021-11-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Malignant tumors are a major disease threatening human life and health.


    Malignant tumors are a major disease threatening human life and health.


    On October 21st, the State Key Laboratory of Cell Stress Biology, the Cell Signal Network Collaborative Innovation Center, and the research group of Zhou Dawang and Chen Lanfen from the School of Life Sciences of Xiamen University jointly published the title Glycogen accumulation and phase separation drives liver tumor in Cell.


     

     

    In this work, the author established a variety of mouse liver cancer models, analyzed early-stage liver tissues and combined with clinical samples of liver cancer, and found that excessive accumulation of glycogen is common in early liver tumor lesions and small tumors.


    In this work, the author established a variety of mouse liver cancer models, analyzed early-stage liver tissues and combined with clinical samples of liver cancer, and found that excessive accumulation of glycogen is common in early liver tumor lesions and small tumors.


    The findings of this work suggest that after the cancer cells in the initiation of early carcinogenesis absorb glucose, they may be stored in the cell as energy in the form of glycogen rather than metabolizing glucose in the form of anaerobic glycolysis


    In order to explore the mechanism of glycogen accumulation in the tumor initiation, the authors used microdissection technology combined with RNA-Seq sequencing to compare and analyze the early tumor focus tissue and adjacent normal tissues, and found that glycogenolytic enzyme G6PC (glucose-6-phosphate) The expression of enzymes in the cancerous lesions decreased significantly, which may be an important factor in the accumulation of glycogen in early cancer foci


    Clinically, inactivating mutations of various glycogenolytic enzymes, including G6PC, PYGL, etc.


    This work further explains that the accumulated sugar phase separation causes the inactivation of the important tumor suppressor Hippo signaling pathway and activates the downstream proto-oncoprotein YAP, thereby driving the initiation of tumors


    Recent studies have shown that the occurrence and development of various tumors is often accompanied by the inactivation of the Hippo pathway that inhibits cell carcinogenesis, but the specific mechanism is still unclear


     

     

    In summary, this work found that early liver tumor cells use the extracted glucose to synthesize glycogen as energy storage, and inhibit the activity of the Hippo signaling pathway through liquid-liquid separation, thereby driving the occurrence and development of tumors


    In summary, this work found that early liver tumor cells use the extracted glucose to synthesize glycogen as energy storage, and inhibit the activity of the Hippo signaling pathway through liquid-liquid separation, thereby driving the occurrence and development of tumors


    This work reveals the pathogenesis of hepatomegaly and liver cancer caused by glycogen accumulation in the clinic, and provides a drug resistance mechanism for the potential survival of tumor cells under stress conditions for the phenomenon of glycogen accumulation in many types of tumor cells.


    Doctoral students Liu Qingxu, Li Jiaxin, Zhang Weiji, Xiao Chen, and postdoctoral fellow Zhang Shihao (currently a professor at Anhui Medical University) from the School of Life Sciences of Xiamen University are the co-first authors of the paper.


    The team of Professor Zhou Dawang and Professor Chen Lanfen intends to recruit several outstanding postdoctoral fellows/researchers to carry out research on tumor immunity .


    Article link:

    https://doi.


    https://doi.
    org/10.
    1016/j.
    cell.
    2021.
    10.
    001

    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.